Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Short term Debt (2020 - 2025)

PROCEPT BioRobotics has reported Short term Debt over the past 4 years, most recently at $2.0 million for Q1 2025.

  • Quarterly results put Short term Debt at $2.0 million for Q1 2025, up 4.49% from a year ago — trailing twelve months through Mar 2025 was $2.0 million (up 4.49% YoY), and the annual figure for FY2024 was $2.0 million, up 6.04%.
  • Short term Debt for Q1 2025 was $2.0 million at PROCEPT BioRobotics, roughly flat from $2.0 million in the prior quarter.
  • Over the last five years, Short term Debt for PRCT hit a ceiling of $2.0 million in Q3 2024 and a floor of $1.9 million in Q4 2023.
  • Median Short term Debt over the past 3 years was $2.0 million (2024), compared with a mean of $2.0 million.
  • Biggest five-year swings in Short term Debt: increased 6.04% in 2024 and later rose 4.49% in 2025.
  • PROCEPT BioRobotics' Short term Debt stood at $1.9 million in 2023, then increased by 6.04% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025.
  • The last three reported values for Short term Debt were $2.0 million (Q1 2025), $2.0 million (Q4 2024), and $2.0 million (Q3 2024) per Business Quant data.